Showing 9031-9040 of 21419 results for "".
Closing the Gaps: Global Implementation of Lipid Guidelines
https://reachmd.com/programs/cme/gaps-global-implementation-lipid-guidelines/54672/A new modular CME-accredited program designed to support clinicians in translating evolving lipid guidelines into everyday practice. Delivered as a 60-minute webcast, divided into chapters for convenience, it integrates U.S. and international perspectives and focuses on equitable cardiovascular careComparing Trial Designs & Outcomes Across IGF-1R Therapies
https://reachmd.com/programs/cme/comparing-trial-designs-outcomes-across-igf-1r-therapies/60945/Explore how experts are rethinking TED severity and integrating modern therapies to personalize treatment and manage individual disease burden.Clearing the Brain Fog: Innovations in the Treatment and Management of Hepatic Encephalopathy
https://reachmd.com/programs/cme/Clearing-the-Brain-Fog-Innovations-in-the-Treatment-and-Management-of-Hepatic-Encephalopathy/39047/Explore diagnostic and treatment challenges in patients with hepatic encephalopathy to improve outcomes for your patients.Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
https://reachmd.com/clinical-practice/cardiology/hypertrophic-cardiomyopathy-moving-from-monitoring-to-action-in-the-era-of-myosin-inhibitors/56461/Find out how myosin inhibitor data support timely identification and treatment of eligible patients with HCM.Moving the Needle in oHCM: The Era of Cardiac Myosin Inhibitors
https://reachmd.com/programs/cme/moving-the-needle-in-ohcm-the-era-of-cardiac-myosin-inhibitors/54822/Explore cardiac myosin inhibitors for obstructive hypertrophic cardiomyopathy (oHCM) with expert insights from ESC Congress 2026 in Munich, Germany.Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 7
https://reachmd.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-7/56875/In the seventh installment of this eight-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, shift to clinical applications, including maintenance therapy, steroid-sparing strategies, and opportunities for future research.1 Draelos Z, HouRedefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
https://reachmd.com/programs/cme/redefining-ohcm-care-efficacy-and-safety-of-myosin-inhibitors/54840/Explore how cardiac myosin inhibitors are reshaping obstructive HCM management, from unmet needs to individualized, evidence-based treatment.From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
https://reachmd.com/programs/cme/from-evidence-to-action-integrating-emerging-myosin-inhibitors-into-ohcm-treatment-plans/54841/Explore how cardiac myosin inhibitors are reshaping obstructive HCM management, from unmet needs to individualized, evidence-based treatment.Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
https://reachmd.com/programs/cme/understanding-igan-fsgs-pathophysiology-and-emerging-therapies/14974/Hear experts discuss how emerging therapies for IgAN and FSGS may achieve proteinuria remission and shape clinical treatment decisions for patients.In Your Waiting Room: The Virtual IBS-C Patient Clinical Experience
https://reachmd.com/programs/cme/in-your-waiting-room-the-virtual-ibs-c-patient-clinical-experience/14955/What else can you do for your patients with IBS-C whose current therapies aren’t enough? Join our experts to explore the stories of 3 patients.